StubHub stock declined 3.4% in afternoon trading to $10.31 as investors remain wary of a package of legal and commercial headwinds that have diminished buying interest. The shares opened at $10.73, ticked up to a session high of $10.94 early in the day, and subsequently slid back toward an intraday low.
Analysts at Citi provided a scenario analysis that has contributed to investor caution. Citi reported that secondary-market tickets on average are being sold at roughly a 65% markup. Their modelling suggests that if markups were constrained to an average of 15%, StubHub’s revenue could fall by about 30% versus current levels.
The Citi team further estimated that if roughly 20% of StubHub’s tickets face resale price caps in 2027, the company’s EBITDA could be reduced by approximately $95 million. Those projections have amplified concerns about the company’s revenue sensitivity to restrictions on resale pricing and the potential profit impact should regulators or platforms impose caps.
The dominant overhang remains an investigation by the Texas Attorney General announced on July 3, 2026. That inquiry centers on multiple reports that StubHub failed to deliver FIFA World Cup 2026 tickets that buyers had already paid for. Authorities have pointed to a pattern described as alleged "ghost ticketing" - instances where sellers list tickets without possessing them, collect payment and then cancel when delivery is impossible. A proposed class action lawsuit tied to these events has increased the company’s legal exposure.
StubHub has attributed the seat cancellations to transfer problems with FIFA’s own ticketing infrastructure. Despite that explanation, the regulatory scrutiny and potential litigation have persisted.
Investors have also been watching recent insider share sales. Taken together with the unresolved regulatory inquiry, the proposed class action, and weakening technical indicators, these factors have kept many buyers on the sidelines. The combined pressure has pushed the stock significantly below its 52-week high of $27.89 and nearer to its 52-week low of $5.74.
For market participants and analysts focused on underwriting quality, funding mix and legal exposure, the present combination of regulatory risk and potential revenue sensitivity to pricing controls has created a challenging near-term outlook for the shares. Until the regulatory questions are settled and clarity emerges on resale pricing constraints, investor caution is likely to persist.